Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 3681-3690 Newer>

Pharmaceutical Executive May 1, 2007 Walter Armstrong	Back Page: Christmas in July 'Tis the season to renew the Prescription Drug User Fee Act, and the tree-hanging party is in full swing.
Pharmaceutical Executive May 1, 2007 Waseem Noor	Toolkit: How To Be a Better Partner Big pharmas and little biotechs have been getting hitched for years. Now it's time to add a little innovation to the relationship. Three new rules will keep the game exciting.
Pharmaceutical Executive May 1, 2007 Sarah Houlton	Global Report: Pure and Simple The european union is set to overhaul the way it monitors drug safety to help make sense of a decentralized system that has been criticized for being ineffective. Will the EC's upcoming drug-safety plan be just what the doctor ordered or end up an indecent proposal?
BusinessWeek May 14, 2007 Arlene Weintraub	Schering-Plough Climbs Out Of Its Sickbed Fred Hassan said getting drugmaker Schering-Plough on its feet might take years. Investors are beginning to see the virtues of patience
HBS Working Knowledge May 4, 2007 Jim Heskett	How Do Managers Think? Observations about doctors raise some interesting questions about how we manage.
The Motley Fool May 4, 2007 Mike Havrilla	Taking It to the Affymax Positive clinical data for a potential anemia treatment has the drugmaker's stock on the rise.
Global Services May 3, 2007 Imrana Khan	Expensive Health-care Boosts Offshoring A recent study says that in India the share of BPO revenue from health-care offshoring will reach $410 million by 2010, due to rising health-care costs in the U.S.
The Motley Fool May 3, 2007 Mike Havrilla	Altus Could Rise to New Heights Altus stands to gain ground if it can successfully advance its two leading drug candidates through clinical trials later this year. Investors, take note.
The Motley Fool May 3, 2007 Brian Orelli	2 Suitors Are Better Than 1 Biosite has two companies vying to acquire it. Investors, take note.
The Motley Fool May 3, 2007 Brian Lawler	Panacos Reveals the Plan The drug developer details the plan for clinical testing of its lead compound and announced its first-quarter financials. Investors, take note.
<Older 3681-3690 Newer> Return to current articles.